166 related articles for article (PubMed ID: 17202374)
1. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation.
Szliter EA; Lighvani S; Barrett RP; Hazlett LD
J Immunol; 2007 Jan; 178(2):1105-14. PubMed ID: 17202374
[TBL] [Abstract][Full Text] [Related]
2. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
McClellan SA; Zhang Y; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
[TBL] [Abstract][Full Text] [Related]
3. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
[TBL] [Abstract][Full Text] [Related]
4. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
5. Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.
Berger EA; Vistisen KS; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7432-9. PubMed ID: 23036997
[TBL] [Abstract][Full Text] [Related]
6. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
7. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling.
Huang X; Hazlett LD; Du W; Barrett RP
J Immunol; 2006 Jul; 177(1):548-56. PubMed ID: 16785552
[TBL] [Abstract][Full Text] [Related]
8. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation.
Rudner XL; Kernacki KA; Barrett RP; Hazlett LD
J Immunol; 2000 Jun; 164(12):6576-82. PubMed ID: 10843717
[TBL] [Abstract][Full Text] [Related]
9. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.
Hazlett LD; McClellan SA; Barrett RP; Huang X; Zhang Y; Wu M; van Rooijen N; Szliter E
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1524-32. PubMed ID: 19892870
[TBL] [Abstract][Full Text] [Related]
10. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
11. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
12. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
Kernacki KA; Barrett RP; Hobden JA; Hazlett LD
J Immunol; 2000 Jan; 164(2):1037-45. PubMed ID: 10623854
[TBL] [Abstract][Full Text] [Related]
13. The role of VIP in cornea.
Jiang X; McClellan SA; Barrett RP; Zhang Y; Foldenauer ME; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7560-6. PubMed ID: 23074208
[TBL] [Abstract][Full Text] [Related]
14. VIP and growth factors in the infected cornea.
Jiang X; McClellan SA; Barrett RP; Berger EA; Zhang Y; Hazlett LD
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6154-61. PubMed ID: 21666233
[TBL] [Abstract][Full Text] [Related]
15. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice.
Hazlett LD; Li Q; Liu J; McClellan S; Du W; Barrett RP
J Immunol; 2007 Jul; 179(2):1138-46. PubMed ID: 17617607
[TBL] [Abstract][Full Text] [Related]
16. Corneal response to Pseudomonas aeruginosa infection.
Hazlett LD
Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.
Carion TW; McWhirter CR; Grewal DK; Berger EA
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6932-40. PubMed ID: 26513498
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
19. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production.
Huang X; McClellan SA; Barrett RP; Hazlett LD
J Immunol; 2002 Jun; 168(11):5756-63. PubMed ID: 12023376
[TBL] [Abstract][Full Text] [Related]
20. Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection.
Zhou Z; Barrett RP; McClellan SA; Zhang Y; Szliter EA; van Rooijen N; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4458-67. PubMed ID: 18566468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
